Adynxx Inc raised $16,000,000 on , from Domain Associates, Tpg Biotech.

Get alertedif Adynxx Inc gets funded!
Amount:$16,000,000
Company:
Investors:,
Industry:Biotechnology
Country:
State:
City:
United States
California
San Francisco
Key people:Stan Abel (Board Director, Director)
Donald C. Manning (CMO)
Dina Gonzalez (Corporate Controller)
Scott Harris (VP, Regulatory Affairs & Product Development)
Kimberly Hebert (Director, Clinical Operations)
Eric Heil (Board Observer)
Julien Mamet (Director, Executive_Officer, Founder & Chief Scientific Officer & Board Director)
William Martin (Director, Operations)
Dennis Podlesak (Board Chairman, Director)
Eckard Weber (Board Director, Director)
Data sources:
www.finsmes.com - Adynxx, a clinical-stage pharmaceutical company, raised $16m in Series B #venturecapital round https://t.co/ULWopLuoA9
bit.ly - Adynxx Closes $16M Series B Financing https://t.co/kHNIvvjlTR https://t.co/EdKnFKZTqL
www.owler.com - Adynxx received $16M in Series B Funding https://t.co/JqEiP8ynm5
dlvr.it - RT @FoundersGyan: Adynxx Closes $16M Series B Financing https://t.co/4o5fCcbGik https://t.co/mToDERm945
www.reuters.com - BRIEF-Adynxx says has raised about $16 mln in equity financing - SEC filing | Reuters
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!